Vertex Pharmaceuticals Q3 Adj. EPS $4.80 Beats $4.56 Estimate, Sales $3.076B Beat $3.053B Estimate

Author: Benzinga Newsdesk | November 03, 2025 04:48pm
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.80 per share which beat the analyst consensus estimate of $4.56 by 5.19 percent. This is a 9.59 percent increase over earnings of $4.38 per share from the same period last year. The company reported quarterly sales of $3.076 billion which beat the analyst consensus estimate of $3.053 billion by 0.74 percent. This is a 10.97 percent increase over sales of $2.772 billion the same period last year.

Posted In: VRTX